首页> 外文OA文献 >Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

【2h】

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

机译：RTOTHERAPY RTOG 0834 / EORTC 26053-22054 / NCIC CTG CEC.1 / CATNON族群试验“新诊断的非1P / 19Q缺失的内塑性胶质瘤的同时和佐剂替替替替莫唑族化疗”：个人病例审查分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
André N. Abrunhosa-Branquinho; Raquel Bar-Deroma; Sandra Collette; Enrico Clementel; Yan Liu; Coen W. Hurkmans; Loïc Feuvret; Karen Van Beek; Martin van den Bent; Brigitta G. Baumert; Damien C. Weber;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis [J] . Abrunhosa-Branquinho Andre N., Bar-Deroma Raquel, Collette Sandra, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2018,第2期

机译：RTOG 0834 / EORTC 26053-22054 / NCIC CTG CEC.1 / CATNON杂项试验的放射疗法质量保证“新诊断的非1P / 19Q缺失的内塑性胶质瘤同时和佐剂替替替莫替莫替斯化疗”：个人案例审查分析
2. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study (vol 390, pg 1645, 2017) [J] . Van den Bent M. J., Baumert B., Erridge S. C., The Lancet . 2017,第10103期

机译：临时结果由CatNon试验（EORTC研究26053-22054）用同时和辅助替替替替莫唑族治疗1P / 19Q非共同缺失的血管瘤：A相3，随机开放标签互动研究（Vol 390，PG 1645， 2017）
3. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study [J] . van den Bent Martin J., Baumert Brigitta, Erridge Sara C., The Lancet . 2017,第10103期

机译：临时结果由CatNon试验（EORTC研究26053-22054）用同时和佐剂替替替替莫替莫替莫替莫替莫替莫替莫替莫族的临时结果，用于1P / 19Q非共缺陷的粘性胶质瘤：A相，随机，开放标签互动研究
4. Radiotherapy Quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON Intergroup trial concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma: individual case review analysis [O] . André N. Abrunhosa-Branquinho, Raquel Bar-Deroma, Sandra Collette, -1

机译：RTOG 0834 / EORTC 26053-22054 / NCIC CTG CEC.1 / CATNON的放射治疗质量保证组间试验新诊断为非1p / 19q缺失的间变性神经胶质瘤的同时和辅助替莫唑胺化疗：个案回顾分析
5. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study [O] . van den Bent, Martin J, Baumert, Brigitta, Erridge, Sara C, 2017

机译：CATNON试验（EORTC研究26053-22054）的中期结果，同时替莫唑胺治疗1p / 19q非共删除的间变性胶质瘤：一项3期随机，开放标签的小组间研究

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

著录项

引文网络

相似文献

相关主题

期刊订阅